ERAP1′s enzymatic activity can impact the risk of these diseases: when increased, the risk for ankylosing spondylitis and psoriasis is elevated, whereas when it is reduced, the risk decreases for Birdshot chorioretinopathy (BSCR) and Behçet’s disease. The gene discussed is ERAP1; the disease is psoriasis.